A new type of magnetic brain stimulation rapidly relieved symptoms of severe depression in 90% of treatment-resistant participants in a small study by Stanford University School of Medicine.
The treatment, called Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT), is a form of transcranial magnetic stimulation approved by the Food and Drug Administration for the treatment of depression.
The therapy improves on current FDA-approved protocols by increasing the number of magnetic pulses, speeding up the pace of the treatment and targeting the pulses according to each patient’s neurocircuitry.
Read more on psychcentral.com